Overexposed: the sun damage that can lead to skin cancer – and how to treat it
Despite the warnings, many of us still overdo it in the summer sun. Here are the main types of skin damage to watch for and what to do about themSummer holidays still mean one thing for many people; basting in the sun until their skin tingles. But though it may top up vitamin D levels, too much sun is undoubtedly a bad thing, especially if you have light skin. One in five of us will get skin cancer at some stage, and there are more cases of skin cancer than all the other cancers put together. Consultant dermatologist Howard Stevens of Skin Care Network says the key messages are simple; avoid the sun between 11am and 3pm, c...
Source: Guardian Unlimited Science - August 16, 2015 Category: Science Authors: Ann Robinson Tags: Health & wellbeing Skin cancer Life and style Society Medical research Science Source Type: news
Non-Melanoma Skin Cancers Seen as Risk in AAV Patients (CME/CE)
(MedPage Today) -- But other malignancies seem no more common than in general population (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - August 12, 2015 Category: Consumer Health News Source Type: news
Non-Melanoma Skin Cancers Seen as Risk in AAV Patients (CME/CE)
(MedPage Today) -- But other malignancies seem no more common than in general population (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 12, 2015 Category: Hematology Source Type: news
Advanced Dermatology and Cosmetic Surgery (ADCS Clinics) Partners with...
Advanced Dermatology and Cosmetic Surgery, the nation’s largest dermatology practice, partners with medical device company to help treat non-melanoma skin cancers and keloids(PRWeb August 07, 2015)Read the full story at http://www.prweb.com/releases/2015/08/prweb12890618.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 7, 2015 Category: Pharmaceuticals Source Type: news
New 'iClusters' identify five subtypes of prostate cancer
Conclusion
Using DNA analysis, this study identified five subgroups (iClusters) of prostate cancer. A large portion of the iCluster-discriminating genes were not previously known to be linked to prostate cancer – an interesting finding in itself. The hope is the iClusters might help doctors treat the disease better based on their specific genetic signature.
However, this study focused on developing reliable subgroups. It did not look at whether the groups improved treatment, disease progression or death rates from prostate cancer. This research is yet to be carried out.
One of the main limitations of the research is i...
Source: NHS News Feed - July 31, 2015 Category: Consumer Health News Tags: Cancer Medical practice Source Type: news
ACOS Holds First Meeting on Best Practices in Superficial Radiation Therapy for Non-Melanoma Skin Cancers
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - June 10, 2015 Category: Pharmaceuticals Source Type: news
Quarter of sun-exposed skin samples had DNA mutations
Conclusion
This study estimated around 25% of normal skin cells have DNA mutations that could prime them to develop into skin cancer in the future. This was a lot higher than the scientists expected.
The genetic analysis of the study was robust, but used skin samples from just four people. This severely limits the generalisablity of the findings to the general population. For example, the results might be different for people of different ages, sun exposures and skin colours, so we don't know if this is true for most people.
Similarly, the researchers only used eyelid cells. There may be something unique about eyelid tiss...
Source: NHS News Feed - May 22, 2015 Category: Consumer Health News Tags: Cancer Lifestyle/exercise Source Type: news
ASCO: Vitamin B3 Derivative Cuts Risk for New Skin Cancers
(MedPage Today) -- Nicotainamide reduces nonmelanoma lesions by a fourth in high-risk patients. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 17, 2015 Category: Primary Care Source Type: news
Vitamin B3 may lower risk of skin cancer
Stephen FellerSYDNEY, May 15 (UPI) -- A form of vitamin B3 has been found to reduce the risk of non-melanoma skin cancers when taken regularly. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 15, 2015 Category: Consumer Health News Source Type: news
Vitamin B3 Helps Prevent Non-Melanoma Skin Cancers in High-Risk Adults
By Amy Orciari Herman
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
Nicotinamide (a form of vitamin B3) reduces the incidence of non-melanoma skin cancers (NMSCs) in high-risk adults, according to study … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 15, 2015 Category: Primary Care Source Type: news
Nicotinamide cuts rate of nonmelanoma skin cancer in those at high risk
Nicotinamide, an inexpensive, over-the-counter form of vitamin B3, is safe and efficacious for the chemoprevention of nonmelanoma skin cancer in patients at high risk, according to data from the Australian Oral Nicotinamide to Reduce Actinic Cancer (ONTRAC) Study.
<a... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 14, 2015 Category: Dermatology Tags: SAN Conference News IMN Conferences FPN Conferences ONCR News ONCR Melanoma & Skin Cancers ONCR Prevention Epidemiology SAN Clinical News SAN News SAN SCN: Actinic Keratosis Source Type: news
B Vitamin Is Found to Help People Prone to Some Types of Skin Cancer
In a clinical trial involving 386 people, participants who received a form of vitamin B3 had a lower risk of getting non-melanoma skin cancer than those who received a placebo. (Source: NYT Health)
Source: NYT Health - May 14, 2015 Category: Consumer Health News Authors: ANDREW POLLACK Tags: Skin Cancer Diona Damian Clinical Trials American Society of Clinical Oncology Melanomas Vitamins Australia Source Type: news
New cancer treatment and prevention studies signal major advances for children and adults
(American Society of Clinical Oncology) The American Society of Clinical Oncology today announced results from four major studies to be presented at ASCO's 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 13, 2015 Category: Cancer & Oncology Source Type: news
Global Non-melanoma Skin Cancer Market Will Grow at 27% CAGR to 2018...
Global Non-melanoma Skin Cancer Market 2014-2018 is a market research report at RnRMarketResearch.com that profiles key players in the Global Non-melanoma Skin Cancer Market like Elekta AB, F....(PRWeb May 07, 2015)Read the full story at http://www.prweb.com/releases/non-melanoma-skin-cancer/market-global-2018/prweb12708173.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 8, 2015 Category: Pharmaceuticals Source Type: news
VIDEO: Updating the immune response to nonmelanoma skin cancer
ASHEVILLE, N.C. – Recent advances in basic science have shown how the local immune environment in tissue surrounding nonmelanoma skin cancer compares to adjacent normal tissue.
New Mexico Health Sciences Center’s Dr. Andrew Ondo reviewed the latest research in <a... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 1, 2015 Category: Dermatology Tags: SAN Video Library SAN Conference News SAN Clinical News SAN News SAN Actinic Keratosis SAN SCN: Squamous Cell Carcinoma ONCR News ONCR Video Library Source Type: news
